| Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication SK Ladner, MJ Otto, CS Barker, K Zaifert, GH Wang, JT Guo, C Seeger, ... Antimicrobial agents and chemotherapy 41 (8), 1715-1720, 1997 | 684 | 1997 |
| Effect of alpha interferon on the hepatitis C virus replicon JT Guo, VV Bichko, C Seeger Journal of virology 75 (18), 8516-8523, 2001 | 575 | 2001 |
| Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections D Jiang, JM Weidner, M Qing, XB Pan, H Guo, C Xu, X Zhang, A Birk, ... Journal of virology 84 (16), 8332-8341, 2010 | 404 | 2010 |
| Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation H Guo, D Jiang, T Zhou, A Cuconati, TM Block, JT Guo Journal of virology 81 (22), 12472-12484, 2007 | 370 | 2007 |
| Present and future therapies of hepatitis B: from discovery to cure TJ Liang, TM Block, BJ McMahon, MG Ghany, S Urban, JT Guo, ... Hepatology 62 (6), 1893-1908, 2015 | 352 | 2015 |
| Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms JM Weidner, D Jiang, XB Pan, J Chang, TM Block, JT Guo Journal of virology 84 (24), 12646-12657, 2010 | 345 | 2010 |
| Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus D Jiang, H Guo, C Xu, J Chang, B Gu, L Wang, TM Block, JT Guo Journal of virology 82 (4), 1665-1678, 2008 | 318 | 2008 |
| Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells J Chang, JT Guo, D Jiang, H Guo, JM Taylor, TM Block Journal of virology 82 (16), 8215-8223, 2008 | 297 | 2008 |
| West Nile virus inhibits the signal transduction pathway of alpha interferon JT Guo, J Hayashi, C Seeger Journal of virology 79 (3), 1343-1350, 2005 | 293 | 2005 |
| Molecular virology of hepatitis B virus for clinicians TM Block, H Guo, JT Guo Clinics in liver disease 11 (4), 685-706, 2007 | 284 | 2007 |
| Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells Q Zhu, JT Guo, C Seeger Journal of virology 77 (17), 9204-9210, 2003 | 277 | 2003 |
| Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation D Cai, C Mills, W Yu, R Yan, CE Aldrich, JR Saputelli, WS Mason, X Xu, ... Antimicrobial agents and chemotherapy 56 (8), 4277-4288, 2012 | 263 | 2012 |
| Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein R Mao, H Nie, D Cai, J Zhang, H Liu, R Yan, A Cuconati, TM Block, ... PLoS pathogens 9 (7), e1003494, 2013 | 252 | 2013 |
| Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections JT Guo, H Zhou, C Liu, C Aldrich, J Saputelli, T Whitaker, MI Barrasa, ... Journal of virology 74 (3), 1495-1505, 2000 | 233 | 2000 |
| DNA polymerase κ is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus Y Qi, Z Gao, G Xu, B Peng, C Liu, H Yan, Q Yao, G Sun, Y Liu, D Tang, ... PLoS pathogens 12 (10), e1005893, 2016 | 207 | 2016 |
| Interferon induction of IFITM proteins promotes infection by human coronavirus OC43 X Zhao, F Guo, F Liu, A Cuconati, J Chang, TM Block, JT Guo Proceedings of the National Academy of Sciences 111 (18), 6756-6761, 2014 | 193 | 2014 |
| Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes F Liu, M Campagna, Y Qi, X Zhao, F Guo, C Xu, S Li, W Li, TM Block, ... PLoS pathogens 9 (9), e1003613, 2013 | 187 | 2013 |
| Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids MR Campagna, F Liu, R Mao, C Mills, D Cai, F Guo, X Zhao, H Ye, ... Journal of virology 87 (12), 6931-6942, 2013 | 183 | 2013 |
| Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics JT Guo, H Guo Antiviral research 122, 91-100, 2015 | 174 | 2015 |
| Broad and differential animal angiotensin-converting enzyme 2 receptor usage by SARS-CoV-2 X Zhao, D Chen, R Szabla, M Zheng, G Li, P Du, S Zheng, X Li, C Song, ... Journal of virology 94 (18), 10.1128/jvi. 00940-20, 2020 | 170 | 2020 |
Timothy BlockPresident and Professor在 bblumberg.org 的电子邮件经过验证
